Arvinas (ARVN) Interest Coverage Ratio (2017 - 2026)
Arvinas' (ARVN) quarterly Interest Coverage Ratio came in at 16.36 in Q1 2026, down 370.36% year-on-year from 6.05 in Q1 2025, and up 91.23% quarter-over-quarter from 186.5 in Q4 2025.
Arvinas (ARVN) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Arvinas' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 16.36 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 370.36% year-over-year to 16.36 in Q1 2026; TTM through Mar 2026 was 65.05, a 702.93% decrease from a year earlier, with the FY2025 full-year figure at 0.25, up 53.62% from the prior year.
- Interest Coverage Ratio grew to 16.36 in Q1 2026 per ARVN's latest filing, from 186.5 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 6.05 in Q1 2025 and bottomed at 330.6 in Q4 2023.
- The 5-year median for Interest Coverage Ratio is 28.6 (2025), against an average of 68.04.
- Across the five-year window, Interest Coverage Ratio plunged 50459.2% in 2022 and surged 114.53% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 189.0 in 2022, then sank by 74.92% to 330.6 in 2023, then jumped by 90.22% to 32.33 in 2024, then slumped by 476.8% to 186.5 in 2025, then surged by 91.23% to 16.36 in 2026.
- Per Business Quant, the three latest ARVN Interest Coverage Ratio figures stand at 16.36 (Q1 2026), 186.5 (Q4 2025), and 17.52 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | -16.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.36 |
| Dec 31, 2025 | -186.50 |
| Sep 30, 2025 | -17.52 |
| Jun 30, 2025 | -28.60 |
| Mar 31, 2025 | 6.05 |
| Dec 31, 2024 | -32.33 |
| Sep 30, 2024 | -67.00 |
| Jun 30, 2024 | -34.64 |
| Mar 31, 2024 | -41.65 |
| Dec 31, 2023 | -330.60 |
| Sep 30, 2023 | -23.84 |
| Jun 30, 2023 | -20.16 |
| Mar 31, 2023 | -20.88 |
| Dec 31, 2022 | -189.00 |
| Sep 30, 2022 | -12.61 |
| Jun 30, 2022 | -131.60 |
| Mar 31, 2022 | -9.46 |
| Dec 31, 2021 | -158.33 |
| Sep 30, 2021 | -0.22 |
| Jun 30, 2021 | -0.26 |